Actively Recruiting

Age: 18Years +
All Genders
NCT06550882

A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

Led by Takeda · Updated on 2025-08-12

9

Participants Needed

1

Research Sites

62 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Acquired hemophilia A (AHA) is a rare bleeding condition which prevents blood clotting. Acquired means that people are not born with this condition or have a family history of blood clotting conditions. People living with AHA can have sudden and severe bleeding. They also have longer bleeding compared to people without AHA. The main aim of the study is to learn how safe OBIZUR is in adults with AHA. Other aims are to see how effective OBIZUR is to control bleeding and how treatment is used in a routine clinical practice setting. The treatment of the participants will be determined by the treating physicians. During the study, data already existing in the participants' medical record and new data will be collected.

CONDITIONS

Official Title

A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants with Acquired Hemophilia A (AHA)
  • Participants who need OBIZUR treatment as determined by their doctor
  • Participants aged 18 years or older at start of OBIZUR treatment
  • Participants who have agreed to join the study and signed informed consent
Not Eligible

You will not qualify if you...

  • Participants allergic to any components of OBIZUR
  • Participants with Congenital Hemophilia A with Inhibitors (CHAWI)
  • Participants for whom OBIZUR treatment is not allowed according to the product label
  • Participants who have joined another clinical study with a medicine or device within 30 days before enrollment or plan to join another such study during this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kyung Hee University Hospital at Gangdong

Seoul, South Korea, 05278

Actively Recruiting

Loading map...

Research Team

T

Takeda Contact

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here